Vanguard Group Inc. Buys 376,904 Shares of Axon Enterprise, Inc $AXON

Vanguard Group Inc. grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 4.2% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 9,314,164 shares of the biotechnology company’s stock after acquiring an additional 376,904 shares during the period. Vanguard Group Inc. owned about 11.86% of Axon Enterprise worth $6,684,217,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Brighton Jones LLC bought a new position in Axon Enterprise during the fourth quarter valued at $480,000. NewEdge Advisors LLC lifted its position in shares of Axon Enterprise by 41.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after buying an additional 668 shares during the last quarter. Empowered Funds LLC grew its stake in shares of Axon Enterprise by 8.4% during the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after acquiring an additional 157 shares during the period. Woodline Partners LP increased its holdings in Axon Enterprise by 40.6% in the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after acquiring an additional 2,003 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in Axon Enterprise in the 2nd quarter worth about $284,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $429.67 on Tuesday. The company’s 50 day simple moving average is $555.10 and its two-hundred day simple moving average is $645.15. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. Axon Enterprise, Inc has a 1 year low of $396.41 and a 1 year high of $885.91. The stock has a market capitalization of $33.91 billion, a PE ratio of 135.97, a P/E/G ratio of 12.94 and a beta of 1.48.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $552.60, for a total value of $11,052,000.00. Following the transaction, the president directly owned 249,502 shares in the company, valued at $137,874,805.20. This represents a 7.42% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $619.01, for a total value of $6,190,100.00. Following the completion of the sale, the chief executive officer directly owned 3,100,997 shares in the company, valued at approximately $1,919,548,152.97. The trade was a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 48,040 shares of company stock valued at $27,249,338 in the last ninety days. 5.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on AXON. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. The Goldman Sachs Group dropped their price target on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research note on Wednesday, November 5th. UBS Group reduced their price objective on shares of Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Wall Street Zen cut shares of Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Finally, Royal Bank Of Canada initiated coverage on Axon Enterprise in a report on Monday, November 17th. They issued an “outperform” rating and a $860.00 price target for the company. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $805.71.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.